Recruiting

Culturally Adapted i-CBT for Farsi/Dari Speaking Migrants

The aim of this randomized controlled trial (RCT) is to investigate the effectiveness of a culturally adapted internet-based cognitive behavioral therapy (i-CBT) intervention in reducing symptoms of common mental health issues among Farsi/Dari-speaking youth migrants and refugees. Investigator hypothesizes that there will be a significant decrease in psychological symptoms after participants receive the intervention compared to a control group.

ClinicalTrials.gov IDNCT06828276

PhaseNA

Enrollment128

SponsorKarolinska Institutet

Age15 Years

SexALL

I'm interested View official listing

Conditions studied

Depressive Symptoms, Anxiety Symptoms, Grief, Psychological Trauma, Insomnia, Resilience, Stress, Psychological Well Being, Marital Relationship, Wellbeing, Common Mental Health Problems, Rumination

About this study

Interventions

Behavioral: Culturally adapted i-CBT — A culturally and language adapted i-CBT intervention for Farsi/Dari speaking youth migrants and refugees. The intervention targets mild to moderate common mental health problems.

Primary outcomes

Hopkins Symptom Checklist-25 (HSCL-25) (Pre-intervention, up to 5 weeks, immediately after the intervention, 6 months after completion of the intervention)

Eligibility information

Inclusion Criteria: * Between the ages of 15 and 29. * A score above the cut-off 1.75 on HSCL-25 * Has a refugee or migrant background * Has a good and stable internet connection * Has access to a computer, tablet or smartphone * Is fluent in reading and writing Arabic * Has the ability to dedicate time to take part in the intervention for 6-10 weeks. Exclusion Criteria: * Is suffering from a severe mental illness, such as psychosis or severe depression. * Is suffering from substance abuse * Is undergoing a psychological treatment * Has a high risk of suicide

Study locations

Karolinska Institutet, Stockholm, 113 64 Sweden

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-10-02.